Levonorgestrel-releasing intrauterine device and uterine perforations

Prescrire International

Volumn 16, Issue 92, 2007, Pages 248-249

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; LEVONORGESTREL;

ARTICLE; FEMALE; FOREIGN BODY; FRANCE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; METRORRHAGIA; UTERUS PERFORATION;

CONTRACEPTIVE AGENTS, FEMALE; FEMALE; FOREIGN-BODY MIGRATION; FRANCE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; METRORRHAGIA; UTERINE PERFORATION;

EID: 38449103381     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Prescrire Editorial Staff "Levonorgestrel intrauterine device" Prescrire Int 1999; 8 (44): 175-177.
2. Agence française des produits de santé (Afssaps) "Commission nationale de pharmacovigilance (compte rendu de la réunion du mardi 31 janvier 2006)" 16 mai 2006. Website afssaps.sante.fr accessed 31 July 2006: 35 pages.
3. Zhou L et al. "Use of the New Zealand intensive medicines monitoring programme to study the levonorgestrel-releasing intrauterine device (Mirena°)" Pharmacoepidemiol Drug Saf 2003; 12: 371-377. (Pubitemid 36903371)
4. Van Houdenhoven K et al. "Uterine perforation in women using a levonorgestrel-releasing intrauterine system" Contraception 2006; 73: 257-260. (Pubitemid 43202176)
5. Health Canada "Levonorgestrel-releasing intrauterine system (Mirena) and uterine perforation" Canadian Adverse Reaction Newsletter 2006; 16 (1):2.